Ulixertinib: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
5
Conditions studied
2
US states with sites
1
Countries
Phase breakdown
Phase 1 2
Conditions being studied
| Condition | Trials |
|---|---|
| Colorectal cancer | 1 |
| Melanoma | 1 |
| Metastatic Colorectal Cancer | 1 |
| Pancreatic Cancer | 1 |
| Tumor, Solid | 1 |
Recruiting trials involving Ulixertinib
- Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
- Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Common questions
How many recruiting trials involve Ulixertinib?
2 recruiting trials across 5 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.